Synthesis and pharmacological evaluation of novel quinoxalines as potential nonulcerogenic anti-inflammatory and analgesic agents

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 12, 2005, Pages 738-743

  Ismail, Magda M F ^a,d   Ammar, Yousry A ^b   Ibrahim, Mohamed K ^a   El Zahaby, Heba S A ^a   Mahmoud, Sawsan S ^c  

^a Al Azhar University   (Egypt)

^b Assiut Branch   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Analgesics; Anti inflammatory drugs, non steroidal; Furoquinoxalines, anti inflammatory and analgesic activities, rat, synthesis; Quinoxalin 2 ones, anti inflammatory and analgesic activities, rat, synthesis

Indexed keywords

4 (6,7 DIMETHYL 3 OXO 3,4 DIHYDROQUINOXALIN 2 YL)PYRAZOLONE; 6 (6,7 DIMETHYL 3 OXO 3,4 DIHYDROQUINOXALIN 2 YL) 3 CYANO 2 (4 ETHOXYANILINO) 4,7 DIHYDROPYRAZOLO[1,5A]PYRIMIDIN 7 ONE; 6 (6,7 DIMETHYL 3 OXO 3,4 DIHYDROQUINOXALIN 2 YL) 3 CYANO 4,7 DIHYDROPYRAZOLO[1,5A]PYRIMIDIN 7 ONE; 6 (6,7 DIMETHYL 3 OXO 3,4 DIHYDROQUINOXALIN 2 YL) 4,7 DIHYDRO 1,2,4 TRIAZOLO[1,5A]PYRIMIDIN 7 ONE; 6,7 DIMETHYL 3 (N,N DIMETHYLCARBAMOYL)FURO[2,3B]QUINOXALINE; 6,7 DIMETHYL 3 HYDRAZINOCARBONYLMETHYLEN 2 OXO 1,2,3,4 TETRAHYDROQUINOXALINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIULCER AGENT; ETHYL 6,7 DIMETHYL 3 OXO 3,4 DIHYDROQUINOXALIN 2(1H)YLIDENE ACETATE; INDOMETACIN; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; RAT; ULCEROGENESIS;

EID: 29744459307     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296923     Document Type: Article

References (16)

1. Sarodnick, G., Kempter, G., Goeres, E. et al., Preparation of N-substituted 2-(aminomethyl) quinoxalines as anti-inflammatory and analgesics; Ger. (East), DD 269, 620 (Cl.CO7D241/42), 05 July 1989, Appl. 272, 581, 15 Jan. 1985, 6 pp. [Chem. Abstr. 112, 139053U (1990)]
2. Karabelas, K., Lonn, H., Sjo, P., Preparation of indolyl-quininoxalines as inhibitors of protein kinase C. (Astra Ab, Sweden), PCT Int. Appl. WO 99 46, 260 (Cl. CO7D 403/04), 16 Sep. 1999, SE. Appl. 1998/836, 13 March 1998, 74 pp. [Chem. Abstr. 131, 214300r (1999)]
3. Piras, S., Loriga, M., Paglietti, G. et al., Synthesis and evaluation of antiulcer and gastroprotective activity of 3-substituted-2-[(arylmethyl)-thio), 2-[(arylmethyl) sulfonyl] and 2-[(piperazinyl)quinoxalines]. Farmaco 51, 569 (1996)
4. Vierfond, J. M., Legendre, L., Martin, C. et al., Thieno- and isothiazolo[3,4-b] quinoxalines: Synthesis, structure and pharmacological study. Eur. J. Med. Chem. 25, 251 (1990)
5. Ali, M. M., Ismail, M. M. E, El-Gaby, M. S. A. et al., Synthesis and antimicrobial activities of some novel quinoxalinone derivatives. Molecules 5, 864 (2000)
6. Ammar, Y. A., El-Gaby, M.S.A., Zahran, M. A. et al., Some reactions with 6-benzoyl-3-amino-2-imino-2,3-dihydrothiazolo [4,5-b] quinoxaline: synthesis of (1,2,4) triazolo[3′,2′:2,3] thiazolo [4,5-b] quinoxaline and (1,3,4) thiadiazino [5,6-b] quinoxaline derivatives. Phosphorous Sulfur Silicon 157, 87 (2000)
7. Ekta, B., Srivastava, V. K., Ashok, K., Synthesis and antiinflammatory activity of 1-acetyl-5-substituted aryl-3-(β-aminonaphthyl)-2-pyrazolines and β-(substituted aminoethyl) amidonaphthalenes. Eur. J. Med. Chem. 36, 81 (2001)
8. Ute, W., Ekkehard, S., 4-Hydroxypyrazolo-[3,4-d]pyrimidine. Ger. Offen. 2, 224, 382 (Cl. C 07d), 6 Dec. 1973, Appl. P 22 24 382.9-44, 18 May 1972, 7 pp. [Chem. Abstr. 80, 59953t (1974)]
9. Kurasawa, Y., Takada, A., Recent progress in the quinoxaline chemistry: Utility of 3-alkoxycarbonylmethylene-2-oxo-1, 2, 3, 4-tetrahydroquinoxalines as starting material. Heterocycles 23, 2083 (1985)
10. Sastry, C. V. R., Marwah, P., Marwah, A. K. et al., Synthesis and biological activity of some new N-arylcarbamoyl and arylthiocarbamoyl hydrazinoquinoxalin-2-ones. Ind. J. Chem. 28B, 885 (1989)
11. Paget, G., Bern, E., Toxicity tests in evaluation of drug activities sited in the laboratory rats. D. R. Laurence, A. L. Bacharach (eds.), p. 135, Academic Press, London (1964)
12. Winter, C. A., Risly, E. A., Nuss, G. W., Carrageenin-induced edema hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544 (1962)
13. Meier, R., Schuler, W., Desaullus, P., Zur Frage des Mechanismus der Hemmung des Bindegewebewachstums durch Cortisone. Experientia (Basel) 6, 469 (1950)
14. Correl, T., Moller, J. K., Splawinski, K., A new anti-inflammatory derivative of imidazole which is less ulcerogenic than indomethacin in rats. Acta Pharmacol. Toxicol. 45, 232 (1979)
15. Charlier, R. P. M., Binon, E, Deltour, G., Pharmacology of an antitussive, 1-phenethyl-4-(2-propynyl)-4-propenoxy piperidine acid fumarate. Arch. Int. Pharmacodyn. 134, 306 (1961)
16. Snedecor, W. G., Cochran, G. W. (eds.), Statistical methods, Iowa State University Press, Ames, Iowa (1971)